THOUSAND OAKS, CA-based Amgen announced plans to open a new technology and innovation site in Hyderabad, India. The site, known as Amgen India, will accelerate digital capabilities across the global organization to further advance Amgen’s pipeline of medicines.
Amgen India will be located in HITEC City, a suburb of Hyderabad, occupying six storeys of the RMZ Spire Tower 110. The city of Hyderabad, located in the state of Telangana, was selected for its world-class talent across medicine, life sciences and data sciences and the rapidly advancing field of artificial intelligence (AI). The site can accommodate up to 3,000 people and will be operational in Q4 2024.
“At a time when a quickly aging global population needs more innovation, the convergence of biotechnology and technology is enabling Amgen to work with greater speed, confidence, and efficiency — an incredibly exciting milestone for which we have been preparing for over a decade,” said David M. Reese, M.D., executive vice president and chief technology officer at Amgen. “Amgen has been a leader in biotechnology for over 40 years and establishing this new site in India, a country known for its world-class technology and life sciences talent, marks a significant step forward in our journey to deliver on our mission to serve patients.”
Amgen has nearly 27,000 employees and has a presence in approximately 100 countries and regions worldwide, including India. To lead Amgen’s expanded presence in India, Som Chattopadhyay has been appointed national executive for India.
“Amgen’s new site in Hyderabad underscores the city’s position as a hub for innovation and technology,” said the state’s Chief Minister, Anumula Revanth Reddy. “We are proud to welcome a global trailblazer of the biotechnology industry,” he noted.
Last updated: December 26th, 2025
